One Health Group PLC

One Health Group PLC

LLSE:OHGR
292.50
GBX
0.00
(0.00%)
3.28BMarket Cap
Nov 30Next Earn
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
2.04
2.18
2.67
2.3
- -
Basic EPS, GAAP
0.01
0.07
0.1
0.15
- -
Free Cash Flow per Basic Share
-0.01
0.18
0.13
0.01
- -
Dividend per Share
0.07
0.06
0.06
0.06
- -
Book Value per Share
0.54
0.47
0.86
0.96
0.96
Tangible Book Value per Share
0.54
0.47
0.86
0.96
0.96
Basic Weighted Avg Shares
10
11
11
14
13
Sales/Revenue/Turnover
21
23
28
32
- -
Operating Margin (%)
1.1
3.92
6.23
7.45
- -
Depreciation Expense
- -
- -
- -
- -
- -
Net Income, GAAP
- -
1
1
2
- -
Effective Tax Rate (%)
24.76
34.54
30.26
23.98
- -
Profit Margin (%)
0.29
3.07
3.8
6.61
- -
Working Capital
4
2
10
9
9
LT Debt
1
- -
1
1
1
Total Equity
6
5
12
13
13
Return on Invested Capital (%)
- -
9.83
10.5
13.46
- -
Return on Capital (%)
- -
12.64
12.18
16.08
- -
Return on Common Equity (%)
- -
13.29
13.05
17.02
- -

Capital Structure

GBP

•

in mil. unless spec.
Sep'26
Mar'26
ST Debt
- -
- -
LT Borrowings
1
1
LT Finance Leases
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
Shares Outstanding
13
14
Market Capitalization
32
33

Working Capital

GBP

•

in mil. unless spec.
Sep'26
Mar'26
Total Current Assets
15
16
Cash, Cash Equivalents & STI
11
11
Accounts Receivable, Net
4
4
Inventories
- -
- -
Total Current Liabilities
7
7
Payables & Accruals
- -
- -
ST Debt
- -
- -
Deferred Revenue
- -
- -

Growth Rates

GBP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
12.21%
Free Cash Flow
- -
- -
-92.78%
Net Income, GAAP
- -
- -
93.58%
Sales/Revenue/Turnover
- -
- -
11.3%
Total Cash Common Dividend
- -
- -
42.65%

Semi-annual Revenue

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
23
2025
- -
- -
28
2026
- -
- -
32

Semi-annual Earnings Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.07
2025
- -
- -
0.1
2026
- -
- -
0.15

Semi-annual Dividends Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.06
2025
- -
- -
0.06
2026
- -
- -
0.06

Company Description

CEO
Adam Rawlinson Binns
Sector
Health services
Industry
Medical/Nursing services
Address
Sheffield United Kingdom
Business
One Health Group PLC is a United Kingdom-based independent healthcare provider delivering National Health Service (NHS) funded elective surgical and diagnostic care. Founded in 2001 and headquartered in Sheffield, South Yorkshire, the company operates under the NHS Patient Choice framework, enabling patients referred through the NHS e-Referral Service (e-RS) to access consultant-led consultations and surgical treatments free at the point of delivery. The company delivers surgical and medical solutions across five core specialties: Orthopaedics, including hip, knee, and shoulder joint replacements, arthroscopic procedures, and peripheral joint repairs; Spinal Surgery, including lumbar decompressions, discectomies, microdiscectomies, and spinal injections; General Surgery, including laparoscopic hernia repairs, cholecystectomies, upper gastrointestinal procedures, and colorectal treatments; Gynaecology, including operative and diagnostic hysteroscopies, laparoscopies, pelvic floor repairs, and minor gynaecological interventions; and Urology, encompassing diagnostic assessments and surgical treatments for urinary tract, bladder, and prostate conditions. In addition to surgical procedures, the group provides comprehensive perioperative pathways comprising initial outpatient consultations; diagnostic imaging coordination; post-operative follow-up reviews; and outpatient physiotherapy and musculoskeletal rehabilitation. One Health Group PLC operates a distributed care delivery model, hosting initial consultations, diagnostics, and recovery care across a regional network of community outreach clinics while conducting surgical operations in partner independent hospital facilities, supported by an accredited network of NHS-affiliated consultant surgeons and anaesthetists. The company primarily serves NHS integrated care boards and patients throughout Yorkshire, Derbyshire, Nottinghamshire, Lincolnshire, Leicestershire, and Humberside. Recent corporate developments include the transfer of the company's public listing from the Aquis Stock Exchange to the AIM market of the London Stock Exchange in March 2025, accompanied by a 7.8 million gross pound capital raise to fund capacity expansion. To scale operating capacity beyond third-party hospital partnerships, the group launched a dedicated surgical hub strategy, securing land in Scunthorpe, Lincolnshire for the construction of its first proprietary surgical facility. In addition, the company expanded its clinical portfolio by formally introducing Urology as a fifth core specialty to address regional elective care backlogs.